HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) 076042.Supplemental Data All Versions of this Article: clinchem.2006.076042v1 53/3/480    most recent Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Pucci, L. Articles by Penno, G. Search for Related Content PubMed PubMed Citation Articles by Pucci, L. Articles by Penno, G. Related Collections Endocrinology and Metabolism

Cystatin C and Estimates of Renal Function: Searching for a Better Measure of Kidney Function in Diabetic Patients

¹ Dipartimento di Endocrinologia e Metabolismo and ² Laboratorio di Analisi Chimiche e Microbiologiche, Azienda Ospedaliero Universitaria di Pisa, Pisa, Italy.

^aAddress correspondence to this author at: Dipartimento di Endocrinologia e Metabolismo, U.O. di Malattie Metaboliche e Diabetologia, Università di Pisa, 56124 Pisa, Italy. Fax 39-050-541521; e-mail plaura{at}immr.med.unipi.it.

Background: Early identification of impairment in renal function is crucial in diabetic patients. Serum cystatin C may be the most sensitive indicator of glomerular filtration rate (GFR) in the clinical setting.

Methods: We compared cystatin C with creatinine, the Cockcroft-Gault (C-G) formula, and the Modification of Diet in Renal Disease (MDRD) study equation for the assessment of early decreased renal function in 288 diabetic patients (125 type 1, 163 type 2) with renal impairment [GFR: 4–222 mL · min^–1 · (1.73 m²)^–1]. Relationships of cystatin C, creatinine, and iohexol clearance were linearized by plotting their reciprocals in a simple regression model. Diagnostic efficiency was calculated from ROC curves.

Results: In this study population, cystatin C (P = 0.0013) was better correlated with GFR (r = 0.857) than were creatinine (r = 0.772), C-G (r = 0.750), and MDRD (r = 0.806), a result replicated in patients with normal renal function (P = 0.023, type 1; P = 0.011, type 2), but not in those with decreased GFR. Mean cystatin C concentrations showed step-by-step statistically significant increases as GFR decreased, allowing very early detection of reduction in renal function. At 90 mL · min^–1 · (1.73 m²)^–1 and 75 mL · min^–1 · (1.73 m²)^–1 cut-points, diagnostic efficiencies of cystatin C (89% and 92%) were better than those of the other variables (79%–82% and 85%–86%, respectively; P = 0.01).

Conclusions: All data supported the value of serum cystatin C compared with conventional estimates based on serum creatinine measurement for detecting very early reduction of renal function. Use of cystatin C to measure renal function will optimize early detection, prevention, and treatment strategies for diabetic nephropathy.

The following articles in journals at HighWire Press have cited this article:

				V. Rigalleau, M.-C. Beauvieux, C. Lasseur, P. Chauveau, C. Raffaitin, C. Perlemoine, N. Barthe, C. Combe, and H. Gin The Combination of Cystatin C and Serum Creatinine Improves the Monitoring of Kidney Function in Patients with Diabetes and Chronic Kidney Disease Clin. Chem., November 1, 2007; 53(11): 1988 - 1989. [Full Text] [PDF]

				A. G.W. Norden, P. Rodriguez-Cutillas, and R. J. Unwin Clinical Urinary Peptidomics: Learning to Walk Before We Can Run Clin. Chem., March 1, 2007; 53(3): 375 - 376. [Full Text] [PDF]